MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies_Pain
Avenue Therapeutics, Inc. (NASDAQ: ATXI)*
Organization & Developments: Avenue Therapeutics
Parents
Avenue Therapeutics, Inc. (NASDAQ: ATXI)*
Children
2020: Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol Nasdaq:ATXI
Avenue Therapeutics, Inc (NASDAQ: ATXI) is a pharmaceutical company focused on developing and commercializing its products principally for use in the acute/intensive care hospital setting.
Its product candidate is intravenous (IV) Tramadol, for the treatment of post-operative acute pain.
Jumps
Finance & Acquisition: Avenue Therapeutics
Key People: Avenue Therapeutics